Tongdu Capital Hosts Precision Medicine Salon Highlighting Investment Opportunities in Oncology
On the afternoon of July 7, over a hundred investors in precision medicine and oncology experts gathered at the “Tsinghua SEM Entrepreneur Accelerator” on Zhongguancun Innovation Street in Beijing for the “Precision Medicine—Innovative Technologies and Business Models in Oncology” salon hosted by Tongdu Shiguang. Many attendees traveled from Shanghai, Jiangxi, and even remote areas to participate. Due to higher-than-expected attendance, the organizers had to make last-minute arrangements to change the venue.
Opening of the 8th Salon by Tongdu Shiguang
This is the eighth thematic salon event hosted by Tongdu Capital, in collaboration with the Tsinghua SEM Entrepreneur Accelerator, VCBeat, and the Tsinghua SEM MBA Student Healthcare Club. Ms. Wu Ronghui, founder of Tongdu Capital, holds a background in biomedical sciences from Tsinghua University and embodies the persevering spirit characteristic of Tsinghua alumni.
“Healthcare is an essential need with high investment barriers, requiring meticulous, long-term efforts,” said Wu Ronghui. “Tongdu Capital aims to build a platform for sharing, communication, and collaboration, working together with all stakeholders to witness and drive the development of the smart healthcare industry.” Tongdu Capital’s partnership with the “Tsinghua SEM Entrepreneur Accelerator” and its collaboration with Intel in the field of medical big data are both endeavors to establish such a platform.
Ms. Wu Ronghui, Founder of Tongdu Capital
Release of the Analysis Report on Entrepreneurship, Investment, and Financing in Smart Health
Yang Chengkui, Vice President of Investment at Tongdu Capital, and Sun Wenxiang, Founder of Lekang Think Tank, released and interpreted the “Analysis Report on Entrepreneurship and Investment & Financing in Smart Health (Q2 2016)” (hereinafter referred to as the “Report”). The Report begins by analyzing the policy environment and the latest guidance from the Political Bureau of the CPC Central Committee, highlighting “favorable policies” and identifying potential opportunities for entrepreneurship and investment.
Mr. Yang Chengkui, Vice President of Investment at Tongdu Capital
The report suggests that favorable policies are creating potential opportunities for entrepreneurship and investment, with two major innovations accelerating: first, innovation driven by the transformation of healthcare service models; second, innovation fueled by big data in health and medical care.
Mr. Sun Wenxiang, Founder of Lekang Think Tank
The report summarizes the “One Platform, Four Portals” framework for national-level health and medical big data. The “One Platform” refers to the improvement of the population health information platform. The “Four Portals” include: health data from the “Prevention Portal,” medical data from the “Clinical Portal,” health data from the “Rehabilitation Portal,” and pharmaceutical sales data from the “Distribution Portal.”
The report also summarizes and forecasts the development trends of entrepreneurship, investment, and financing in China’s smart health sector through an analysis of segmented markets, while providing a comparative analysis with the situation in the United States.
The report indicates that, in addition to emerging medical media and internet-based healthcare service platforms, large pharmaceutical companies, internet giants, certain healthcare institutions/government bodies, and insurance organizations have all taken action to commit themselves to the smart health industry.
Business Opportunities in Precision Medicine Become Prominent
This salon delved into the latest innovations in precision medicine, particularly highlighting innovative technologies and business models in oncology. Attendees believed that the entire industry may experience explosive growth opportunities in the coming years.
Precision medicine is being gradually implemented as a national strategy. In March 2015, the Ministry of Science and Technology convened China’s first expert meeting on precision medicine strategy, proposing the Chinese Precision Medicine Plan. The meeting indicated that China would invest RMB 60 billion in the field of precision medicine by 2030. In March 2016, precision medicine was included in the National Key Research and Development Program, and efforts were made to include it in the national medical insurance reimbursement list, which is expected to break through key bottlenecks hindering the large-scale commercialization of precision medicine.
Oncology is a representative field of precision medicine. Gao Xianshu, Chairman of the Radiotherapy Professional Committee of the Chinese Research Hospital Association and a leading expert in radiotherapy in China, pointed out that the overall five-year survival rate in China is 39.9%, compared to 66% in the United States. “This indicates significant room for medical development and a vast market demand for cancer treatment.”
Mr. Gao Xianshu, Chair of the Radiotherapy Professional Committee of the Chinese Research Hospital Association and a leading expert in the field of radiotherapy in China
Dr. Hu Zhiyuan, an expert in the field of tumor detection, currently serves as the Director of the Laboratory for Nanotranslational Medicine at the National Center for Nanoscience and Technology. The “Tumor Catcher” project he founded is advancing liquid biopsy technology. “Once mass-produced, the cost will be reduced to a few hundred yuan. This sector is highly promising; JPMorgan Chase estimates the global market to be worth over tens of billions of dollars,” said Dr. Hu.
Dr. Hu Zhiyuan, Expert in the Field of Tumor Detection
What New Opportunities Lie Ahead in Oncology? This Was the Key Topic of Discussion at the Salon.
Time Together Seminar Salon: What New Opportunities Will Emerge in the Field of Oncology?
Wang Jie, Chief Expert at Kang'ai DoctorsJun pointed out, “Cancer treatment in China is not excessive but rather non-standardized. The urgent priority is to standardize treatment, implement effective solutions, ensure affordability for patients, and achieve robust data accumulation.”
Li Xiaomin, Partner at Chunfeng Venture Capital“He believes that ‘some mobile health companies are attempting to integrate with insurance providers, hospitals, and pharmaceutical manufacturers; this is a highly promising model, representing significant opportunities.’”
Luo Ligang, Co-founder of LinkDoc Technology“Big data should be the future direction in oncology. Integrating oncology big data with genomic data, health data, and early-stage diagnosis and treatment data can better serve society.”
Wu Wenhui, Founder of Jiufeng MedicalHe stated, “With current technological capabilities, it is crucial to capitalize on the initial imaging examination for tumor patients to prevent missed or misdiagnoses and enable early treatment.”
Zhang Yang, Founder of Purun Kangqiaostated, “Ensuring that patients can receive treatment for minor illnesses within their townships and for serious conditions within their counties, thereby implementing tiered diagnosis and treatment at the county level, is also a response to the national call.”
Wu Ronghui, Founder of Tongdu CapitalIn summarizing the salon, he stated, “The development of the smart health sector is particularly exciting and instills great confidence in the future. We welcome talents from all fields to join this growing workforce.”
★To read the full text of the “Analysis Report on Entrepreneurship, Investment and Financing in Smart Healthcare (Q2 2016),” please leave a message on the VCBeat official account along with your frequently used email address. We will send it to you next week.